May 28, 2019 7:30am EDT ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau
Mar 21, 2019 2:47pm EDT Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
Mar 19, 2019 7:30am EDT ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD™ 2019 Conference
Feb 21, 2019 7:30am EST ProMIS Neurosciences Adds Pharmaceutical Leader Timothy Rothwell to Board of Advisors
Jan 31, 2019 7:30am EST Selectivity for the Toxic Oligomer Essential to Treating Root Cause of Alzheimer's Disease
Jan 17, 2019 7:30am EST ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences